Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,964.40
(
0.92%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
96.44
(
-4.68%
)
Bitcoin
76,674.00
(
-0.77%
)
News Focus
News Focus
Post# of 518776
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

XenaLives

Member Level

Re: Investor2014 post# 205620

Sunday, 08/11/2019 4:11:40 AM

Sunday, August 11, 2019 4:11:40 AM

Post# of 518776
What if ???

What if the Alzheimer's trial is on the back burner?

Previous Alzheimer's trials have been large numbers of people and long duration.

If PDD and Rett are successful they are easier to approve on shorter duration trials. This will give justification for a shorter Alzheimer's trial and provisional approval for all three indications.

Just speculating that Missling might have a good reason to be tight lipped about all of this.



In Peace, In War

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News